Medi Assist Health Ser L carries a market capitalization of 27.20B, placing it among publicly traded companies globally. Its enterprise value stands at 20.05B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 27.20B |
| Enterprise Value | 20.05B |
Medi Assist Health Ser L currently has 74.61M shares outstanding.
| Shares Outstanding | 74.61M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Medi Assist Health Ser L trades at a trailing price-to-earnings ratio of 24.92. The price-to-sales ratio is 2.42, and the price-to-book ratio stands at 58.75.
| PE Ratio | 24.92 |
| PS Ratio | 2.42 |
| PB Ratio | 58.75 |
| P/TBV Ratio | 7.63 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Medi Assist Health Ser L trades at an EV/EBITDA multiple of 20.56 and an EV/FCF ratio of 84.23. The EV/Sales ratio of 2.22 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 20.56 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.22 |
| EV / EBITDA | 20.56 |
| EV / EBIT | 20.56 |
| EV / FCF | 84.23 |
Medi Assist Health Ser L maintains a current ratio of 1.34, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.38, indicating elevated leverage, while an interest coverage ratio of 4.55 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.34 |
| Quick Ratio | 0.58 |
| Debt / Equity | 6.38 |
| Debt / EBITDA | 0.56 |
| Interest Coverage | 4.55 |
| Return on Equity (ROE) | 38.19 |
| Return on Assets (ROA) | 6.95 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 29.09 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Medi Assist Health Ser L has paid -89.59M in income taxes, reflecting an effective tax rate of 117.09.
| Income Tax | -89.59M |
| Effective Tax Rate | 117.09 |
Medi Assist Health Ser L's stock has declined approximately -30.34912% over the past 52 weeks. The 50-day moving average sits at 366.44, while the 200-day moving average is 418.19.
| Beta (5Y) | N/A |
| 52-Week Price Change | -30.34912% |
| 50-Day Moving Average | 366.44 |
| 200-Day Moving Average | 418.19 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Medi Assist Health Ser L generated 9.05B in revenue and converted that into 879.57M in net income, yielding earnings per share of 12.05. EBITDA reached 974.82M, while operating income came in at 974.82M.
| Revenue | 9.05B |
| Gross Profit | 5.11B |
| Operating Income | 974.82M |
| Pretax Income | 803.52M |
| Net Income | 879.57M |
| EBITDA | 974.82M |
| EBIT | 974.82M |
| Earnings Per Share (EPS) | 12.05 |
Medi Assist Health Ser L holds 2.55B in cash and equivalents against 543.98M in total debt, resulting in a net debt position of -546.32M. Total book value stands at 373.05M, with working capital of 1.48B providing operational flexibility.
| Cash & Cash Equivalents | 2.55B |
| Total Debt | 543.98M |
| Net Debt | -546.32M |
| Equity (Book Value) | 373.05M |
| Book Value Per Share | 5.05 |
| Working Capital | 1.48B |
Medi Assist Health Ser L operates with a gross margin of 56.44, reflecting its pricing power and cost economics. The operating margin of 10.77 and net profit margin of 9.72 provide insight into operational efficiency.
| Gross Margin | 56.44 |
| Operating Margin | 10.77 |
| Pretax Margin | 8.88 |
| Profit Margin | 9.72 |
| EBITDA Margin | 10.77 |
Medi Assist Health Ser L posts an Altman Z-Score of 4.27, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.27 |